Literature DB >> 17274776

Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG).

Margitta Worm1, Werner Aberer, Monika Agathos, Detlef Becker, Jochen Brasch, Thomas Fuchs, Uwe Hillen, Peter Höger, Vera Mahler, Axel Schnuch, Christiane Szliska.   

Abstract

Allergic contact dermatitis occurs frequently in children. Patch testing is needed to identify the responsible allergens and should be performed in children. We recommend a panel of 12 contact allergens as a standard series in children from 6-12 years. Four additional contact allergens should be tested in case of a positive history or suggestive clinical picture. For patch testing in children, the allergens should be applied for 24 hours and the readings should be performed at 48 and 72 hours. Standardized patch testing makes it possible to systematically investigate allergic contact dermatitis and identify relevant allergens in children.

Entities:  

Mesh:

Year:  2007        PMID: 17274776     DOI: 10.1111/j.1610-0387.2007.06175.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  5 in total

Review 1.  Allergic contact dermatitis in children: review of the past decade.

Authors:  Shehla Admani; Sharon E Jacob
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

2.  Invited commentary: recommendation for a north american pediatric patch test series.

Authors:  Sharon E Jacob; Shehla Admani; Elise M Herro
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 3.  [Basis for the treatment of eczematous diseases in otorhinolaryngology].

Authors:  R Fölster-Holst; A Sperl; T Albrecht; L Klimek
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

4.  [Contact allergy in children].

Authors:  J Brasch
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

5.  [Not Available].

Authors:  M Worm; U Lippert; J Geier; A Schnuch
Journal:  Hautarzt       Date:  2015-09       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.